PMC6060005

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Among pregnant women with OUD, those who experienced an overdose had significantly higher rates of homelessness (79% vs 34%), anxiety (82% vs 60%), and depression (85% vs 61%) compared to women with O

Effect: decline; 79% homelessness with overdose vs 34% OUD without overdose vs 2% no OUD; 82% anxiety with overdose vs 60% OUD without overdose vs 18% no OUD;

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste